$TWST News

Twist Bioscience to Report Fiscal 2026 Fourth Quarter and Full Year Financial Results on Thursday, November 12, 2026

TD Cowen Maintains Buy on Twist Bioscience, Raises Price Target to $190

Is Twist Bioscience (TWST) Quietly Becoming Core Infrastructure for AI-Driven Biofoundry Platforms?

Canaccord Genuity Maintains Buy on Twist Bioscience, Raises Price Target to $205

Jefferies Initiates Coverage On Twist Bioscience with Hold Rating, Announces Price Target of $150

Twist Bioscience: Valuation Stretched As AI Drug Discovery Hype Outpaces Reality

Barclays Maintains Overweight on Twist Bioscience, Raises Price Target to $215

$1000 Invested In Twist Bioscience 5 Years Ago Would Be Worth This Much Today

Twist Bioscience (TWST) Stock Fair Value Edges Higher As Analysts Split On AI Upside

Twist Bioscience (TWST) Stock Could Be Reasonable On Its 9x Three Year Run

Guggenheim Maintains Buy on Twist Bioscience, Raises Price Target to $212

Leerink Partners Maintains Outperform on Twist Bioscience, Raises Price Target to $190

Twist Bioscience: Don't Confuse A Short Squeeze With An AI Revolution

Twist Bioscience Stock Hits New High, Then Retreats: What's Happening?

Twist Bioscience Stock Jumped 16% Thursday. Leerink Says Anthropic Made It Happen.

Practice Caution with This Hot Stock Up 493% in the Past Year

TWST Stock Hits Multi-Year High, But ‘Pharma Bro’ Martin Shkreli Calls Twist A Short

HAE, TWST Stocks Jump To Over 5-Year Highs – What’s Driving The Gains Today?

Twist Bioscience (TWST) Is Up 14.0% After Lilly AI Drug Discovery Tie-Up Is Announced - Has The Bull Case Changed?

AI and Next-Gen Sequencing Strengthens Twist Bioscience Corp. (TWST)